Projected Income Statement: Pandox AB

Forecast Balance Sheet: Pandox AB

Forecast Balance Sheet - Pandox AB
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 31,030 35,464 34,857 37,413 51,860 48,314 48,414 48,538
Change - 14.29% -1.71% 7.33% 38.61% -6.84% 0.21% 0.26%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Cash Flow Forecast: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 531 898 2,375 1,024 1,087 1,251 1,193 1,217
Change - 69.11% 164.48% -56.88% 6.15% 15.09% -4.68% 2.02%
Free Cash Flow (FCF) 1 -1,091 740 712 802 2,014 12,152 1,797 1,640
Change - 167.83% -3.78% 12.64% 151.12% 503.38% -85.21% -8.76%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Forecast Financial Ratios: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 57.07% 58.44% 53.96% 55.51% 54.71% 61.67% 61.76% 61.66%
EBIT Margin (%) 47.97% 52.19% 53.44% 51.22% 53.37% 58.87% 59.06% 58.96%
EBT Margin (%) 27.07% 94.64% -7.26% 33.06% 51.49% 37.45% 39.15% 39.51%
Net margin (%) 18.64% 74.58% -8.54% 23.67% 42.03% 27.24% 30.05% 30.25%
FCF margin (%) -33.33% 13.09% 10.4% 11.24% 26.96% 144.36% 20.68% 18.4%
FCF / Net Income (%) -178.85% 17.55% -121.71% 47.48% 64.16% 530.05% 68.83% 60.83%

Profitability

        
ROA 0.93% 5.94% -0.79% 2.19% - - - -
ROE 2.49% 15.08% -1.94% 5.35% 9.33% 5.99% 5.66% 5.52%

Financial Health

        
Leverage (Debt/EBITDA) 16.61x 10.73x 9.43x 9.45x 12.69x 9.31x 9.02x 8.83x
Debt / Free cash flow -28.44x 47.92x 48.96x 46.65x 25.75x 3.98x 26.94x 29.61x

Capital Intensity

        
CAPEX / Current Assets (%) 16.22% 15.88% 34.68% 14.35% 14.55% 14.86% 13.73% 13.65%
CAPEX / EBITDA (%) 28.43% 27.18% 64.26% 25.85% 26.6% 24.1% 22.22% 22.15%
CAPEX / FCF (%) -48.67% 121.35% 333.57% 127.68% 53.97% 10.29% 66.36% 74.21%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - 2.5 4 4.25 4.5 4.75 5.114 5.458
Change - - 60% 6.25% 5.88% 5.56% 7.65% 6.74%
Book Value Per Share 1 137.1 167.2 160.8 172.3 173.3 183.3 195.9 208.5
Change - 21.89% -3.77% 7.11% 0.6% 5.75% 6.9% 6.42%
EPS 1 3.32 22.94 -3.18 9.04 16.13 12.86 13.95 15.31
Change - 590.96% -113.86% 384.28% 78.43% -20.27% 8.47% 9.76%
Nbr of stocks (in thousands) 183,850 183,850 183,850 194,603 194,603 194,603 194,603 194,603
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK
Estimates
2026 *2027 *
P/E 11.7x 10.8x
PBR 0.82x 0.77x
EV / Sales 9.22x 8.95x
Yield 3.15% 3.4%

EPS & Dividend

EPS & Dividend - Pandox AB


Y-o-Y evolution of P/E

Valuation ratios - P/E - Pandox AB
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Pandox AB
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Pandox AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
150.60SEK
Average target price
204.60SEK
Spread / Average Target
+35.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Pandox AB